ID   1383D2
AC   CVCL_UP38
SY   HPS1005
DR   RCB; HPS1005
DR   Wikidata; Q93298761
RX   Patent=US20200407693;
RX   PubMed=28453617;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Asian.
CC   HLA typing: A*02:07,32:01; B*15:02,51:01; C*08:01;14:02; DQA1*03:03,06:01; DQB1*03:01,03:02; DRB1*04:05,12:01 (PubMed=30853558).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP39 ! 1383D6
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
CH   CVCL_C1FK ! 1383D2-B2M-KO #1
CH   CVCL_C1FL ! 1383D2-B2M-KO #2
//
RX   Patent=US20200407693;
RA   Hotta, Akitsu
RA   Xu, Huai-Geng
RA   Kaneko, Shin
RA   Wang, Bo
RT   "Method for producing low-antigenic cell.";
RL   Patent number US20200407693, 31-Dec-2020.
//
RX   PubMed=28453617; DOI=10.1093/biolre/iox038;
RA   Yokobayashi, Shihori
RA   Okita, Keisuke
RA   Nakagawa, Masato
RA   Nakamura, Tomonori
RA   Yabuta, Yukihiro
RA   Yamamoto, Takuya
RA   Saitou, Mitinori
RT   "Clonal variation of human induced pluripotent stem cells for
RT   induction into the germ cell fate.";
RL   Biol. Reprod. 96:1154-1166(2017).
//
RX   PubMed=30853558; DOI=10.1016/j.stem.2019.02.005;
RA   Xu, Huai-Geng
RA   Wang, Bo
RA   Ono, Miyuki
RA   Kagita, Akihiro
RA   Fujii, Kaho
RA   Sasakawa, Noriko
RA   Ueda, Tatsuki
RA   Gee, Peter
RA   Nishikawa, Misato
RA   Nomura, Masaki
RA   Kitaoka, Fumiyo
RA   Takahashi, Tomoko
RA   Okita, Keisuke
RA   Yoshida, Yoshinori
RA   Kaneko, Shin
RA   Hotta, Akitsu
RT   "Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with
RT   enhanced immune compatibility.";
RL   Cell Stem Cell 24:566-578.e7(2019).
//